Risultati della ricerca - Denise M. Wolf
- Mostra 1 - 20 risultati su 39
- Vai alla pagina seguente
-
1
The Bacillus subtilis sin Operon di Christopher A. Voigt, Denise M. Wolf, Adam P. Arkin
Pubblicazione 2004Artigo -
2
Androgen receptor gene expression in primary breast cancer di Neelima Vidula, Christina Yau, Denise M. Wolf, Hope S. Rugo
Pubblicazione 2019Artigo -
3
Modularity of stress response evolution di Amoolya H. Singh, Denise M. Wolf, Peggy Wang, Adam P. Arkin
Pubblicazione 2008Artigo -
4
-
5
-
6
-
7
-
8
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma di Edward W. Roberts, Miranda L. Broz, Mikhail Binnewies, Mark B. Headley, Amanda E. Nelson, Denise M. Wolf, Tsuneyasu Kaisho, Dusan Bogunovic, Nina Bhardwaj, Matthew F. Krummel
Pubblicazione 2016Artigo -
9
Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response di Mark Jesus M. Magbanua, Denise M. Wolf, Christina Yau, Sarah Davis, Julia Crothers, Alfred Au, Christopher M. Haqq, Chad Livasy, Hope S. Rugo, Laura J. Esserman, John W. Park, Laura van ’t Veer
Pubblicazione 2015Artigo -
10
ENPP1 is an innate immune checkpoint of the anticancer cGAMP–STING pathway in breast cancer di Songnan Wang, Volker Böhnert, Alby J. Joseph, Valentino Sudaryo, Gemini Skariah, Jason Swinderman, Feiqiao Brian Yu, Vishvak Subramanyam, Denise M. Wolf, Xuchao Lyu, Luke A. Gilbert, Laura J. vanʼt Veer, Hani Goodarzi, Lingyin Li
Pubblicazione 2023Artigo -
11
Expression profiling of circulating tumor cells in metastatic breast cancer di Julie E. Lang, Janet H. Scott, Denise M. Wolf, Petr Novák, Vasu Punj, Mark Jesus M. Magbanua, Weizhu Zhu, Neal Mineyev, Christopher M. Haqq, Julia Crothers, Laura J. Esserman, Debasish Tripathy, Laura van ‘t Veer, John W. Park
Pubblicazione 2014Artigo -
12
Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle di Imke H. Bartelink, Ella F. Jones, Sheerin Shahidi-Latham, Pei Rong Evelyn Lee, Yanan Zheng, Paolo Vicini, Laura van ‘t Veer, Denise M. Wolf, Andrei Iagaru, Deanna L. Kroetz, Brendan Prideaux, Cornelius Cilliers, Greg M. Thurber, Zéna Wimana, Géraldine Gebhart
Pubblicazione 2018Revisão -
13
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib di Anneleen Daemen, Denise M. Wolf, James E. Korkola, Obi L. Griffith, Jessica Frankum, Rachel Brough, Lakshmi R. Jakkula, Nicholas J. Wang, Rachael Natrajan, Jorge S. Reis‐Filho, Christopher J. Lord, Alan Ashworth, Paul T. Spellman, Joe W. Gray, Laura J. vanʼt Veer
Pubblicazione 2012Artigo -
14
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity di Miranda L. Broz, Mikhail Binnewies, Bijan Boldajipour, Amanda E. Nelson, Joshua L. Pollack, David J. Erle, Andrea J. Barczak, Michael Rosenblum, Adil Daud, Diane L. Barber, Sebastián Amigorena, Laura J. vanʼt Veer, Anne I. Sperling, Denise M. Wolf, Matthew F. Krummel
Pubblicazione 2014Artigo -
15
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity di Miranda L. Broz, Mikhail Binnewies, Bijan Boldajipour, Amanda E. Nelson, Joshua L. Pollack, David J. Erle, Andrea J. Barczak, Michael D. Rosenblum, Adil Daud, Diane L. Barber, Sebastián Amigorena, Laura J. vanʼt Veer, Anne I. Sperling, Denise M. Wolf, Matthew F. Krummel
Pubblicazione 2014Artigo -
16
Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance) di Mark Jesus M. Magbanua, Hope S. Rugo, Denise M. Wolf, Louai Hauranieh, Ritu Roy, Praveen Pendyala, Eduardo V. Sosa, Janet H. Scott, Jin Sun Lee, Brandelyn N. Pitcher, Terry Hyslop, William T. Barry, Steven J. Isakoff, Maura N. Dickler, Laura van’t Veer, John W. Park
Pubblicazione 2018Artigo -
17
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer di Kim Blenman, Michał Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Ibrahim, Tristen Park, Andrea Silber, Denise M. Wolf, Emily Reisenbichler, Carsten Denkert, Bruno V. Sinn, Mariya Rozenblit, Julia Foldi, David L. Rimm, Sibylle Loibl, Lajos Pusztai
Pubblicazione 2022Artigo -
18
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk di Mark Jesus M. Magbanua, Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown Swigart, David C. Newitt, Jessica Gibbs, Amy L. Delson, Ekaterina Kalashnikova, Alexey Aleshin, Bernhard Zimmermann, A. Jo Chien, Debu Tripathy, Laura J. Esserman, Nola M. Hylton, Laura van ‘t Veer
Pubblicazione 2021Artigo -
19
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting di Tesa Severson, Denise M. Wolf, Christina Yau, Justine Peeters, Diederik Wehkam, Philip C. Schouten, Suet‐Feung Chin, Ian J. Majewski, Magali Michaut, Astrid Bosma, Bernard Pereira, Tycho Bismeijer, Lodewyk F.A. Wessels, Carlos Caldas, René Bernards, Iris Simón, Annuska M. Glas, Sabine C. Linn, Laura van ‘t Veer
Pubblicazione 2017Artigo -
20
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities di Jean‐Philippe Coppé, Miki Mori, Bo Pan, Christina Yau, Denise M. Wolf, Ana Ruiz-Sáenz, Diede Brunen, Anirudh Prahallad, Paulien Cornelissen‐Steijger, Kristel Kemper, Christian Posch, Changjun Wang, Courtney A. Dreyer, Oscar Krijgsman, Pei Rong Evelyn Lee, Zhongzhong Chen, Daniel S. Peeper, Mark M. Moasser, René Bernards, Laura van ‘t Veer
Pubblicazione 2019Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Cancer
Cancer research
Gene
Genetics
Medicine
Breast cancer
Internal medicine
Oncology
Biochemistry
Computational biology
Immunology
Immune system
Chemotherapy
Gene expression
Neoadjuvant therapy
Bioinformatics
Biomarker
Cell biology
Computer science
Cytotoxic T cell
In vitro
Metastasis
Poly ADP ribose polymerase
Polymerase
Triple-negative breast cancer
Antigen
Bacillus subtilis
Bacteria
Cell